Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

HDFC Life Insurance Company - Recovery well on track post Covid-19 dip - ICICI Securities

Posted On: 2020-10-19 22:14:58


HDFC Life (HDLI) continues with its diversified product/distribution strategy with strong recovery in Q2FY21 (Total APE growth of 21% in Q2FY21 compared to 30% decline in Q1FY21) leading to 135bps QoQ improvement in VNB margin to 25.7%. H1FY21 VNB margin stood at 25.1%. VNB grew 22%/89% YoY/QoQ to Rs5.5bn in Q2FY21. Product suite is stronger with new high-margin par and group protection products. Persistency has also recovered for ULIPs to pre-Covid levels, while non-par book intrinsically has higher persistency. The strong volume performance in H1FY21 and improving outlook on credit disbursement on a backdrop of business recovery from Covid-19 posit tailwinds to VNB estimates.

- Upgrade to BUY from Add. We value HDLI at 40x new business value of Rs26bn in FY22E (unchanged). At our target price of Rs663, FY22E P/EV stands at 4.6x.

- Embedded value has increased from Rs206bn in FY20 to Rs233bn in H1FY21. We factor EV of Rs246bn/Rs290bn (unchanged) in FY21/22E based on 7.5% unwind, 26%/30% VNB margin and 3%/20% APE growth in FY21/22, respectively. There could be higher-than-expected APE growth in FY21 considering the H1FY21 performance and lower base of H2FY20. Additionally, the recovery of credit protect (down 74%/36%/53% YoY in Q1/Q2/H1FY21) would provide additional margin and volume tailwinds. (Refer Table 5 for credit commentary of HDFC Life's partners)

- Bancassurance outperforms (with large impact of HDFC Bank) in Q2FY21. In terms of individual APE, bancassurance and agency channel registered growth of 38% and 8% YoY, respectively, in Q2FY21. HDFC Bank remains ~70% of the banca mix of HDLI. Management indicated green shoots in other channels in Q2 (ex-HDFC banca channel grew 6% in Q2FY21).

- Operating performance remains disciplined: 13th month persistency ratios for individual business improved from 86% in H1FY20 to 88% in H2FY22 (benefits of guaranteed savings that should continue). 61M persistency ratio remained steady at 53%. Management indicated that persistency in ULIPs has been restored to pre- Covid levels. As on H1FY21, solvency ratio stood at 203%. Total expenses to Total premium stood 15.2% in H1FY21 vs 19.2% in H1FY20. Some cost savings will get reversed with expected growth.

- HDLI is adopting a mezzanine protection pricing strategy between IPRU Life and SBI Life. HDLI has been reserved to increase protection pricing only driven by actuarial judgements. This is a mezzanine strategy between IPRU Life (intended to fully pass reinsurance rate hikes) and SBI Life (no increase in protection prices yet).

- Balanced product mix remains the strategy; new products to strengthen the product mix. Based on individual APE, ULIP, par and non-par savings remain at 23%, 33% and 30%, respectively, of the mix in H1FY21. There is a rise in par mix (new product Sanchay Par Advantage has higher margin profile because of higher duration).

Shares of HDFC Life Insurance Company Ltd was last trading in BSE at Rs.570.65 as compared to the previous close of Rs. 561.45. The total number of shares traded during the day was 138336 in over 6297 trades.

The stock hit an intraday high of Rs. 574.25 and intraday low of 564.6. The net turnover during the day was Rs. 78799965.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com



Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct

Vodafone Idea Positive development beneficial for IDFC first bank - Angel Broking

Lakshmi Vilas Bank - Angel Broking

WIPRO Buyback record date announcement - Angel Broking

TCS buyback record date announcement - Angel Broking

Banks Sector Update - Collection efficiency - a positive surprise! - HDFC Securities

Quant Pick - Max Financial Services - ICICI Direct

Graphite India - Q2FY21 Result Update - ICICI Direct

Gladiator Stocks - Maruti Suzuki India - ICICI Direct

Exide Industries - Q2FY21 Result Update - ICICI Direct

Mishra Dhatu Nigam - Execution outlook remains strong - ICICI Securities

Bharat Electronics - Diversifying into multiple revenue streams - ICICI Securities

Wipro Ltd - Virtual Analyst Meet Update - ICICI Direct

Avadh Sugar & Energy - November 2020 - Company Update - ICICI Direct

Mahindra Lifespace Developers - H1FY21 Company Update - ICICI Direct

Quant Pick - Godrej Consumer Products - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019